Sundial Files Early Warning Report Issued Pursuant to National Instrument 62-103

Rhea-AI Summary

Sundial Growers Inc. announced it acquired over 10% of The Valens Company Inc. on May 3, 2021, purchasing 538,400 shares at $3.663 each for a total of $1.972 million. Following this acquisition, Sundial now holds 16,040,200 Common Shares of Valens, equating to approximately 10.1% of the total issued shares. Sundial's average cost for these shares is $2.670. The acquisition is part of Sundial's investment strategy, which may evolve based on market conditions. This announcement aligns with compliance requirements under Canadian securities law.

Positive

• Increased ownership stake in Valens to approximately 10.1%, enhancing Sundial's influence.
• Strategic investment at an average cost base of $2.670 per share, below the current market price.

Negative

• None.

CALGARY, AB, May 4, 2021 /PRNewswire/ - Sundial Growers Inc. (NASDAQ: SNDL) ("Sundial" or the "Company") announced that it has acquired (the "Acquisition") more than 10% of the issued outstanding common shares ("Common Shares") of The Valens Company Inc. ("Valens") (TSX: VLNS) (OTCQX: VLNCF).

On May 3, 2021, Sundial acquired 538,400 Common Shares at a price of $3.663 per Common Share (the "Transaction") for total consideration of $1.972 million. Immediately before the completion of the Transaction, Sundial owned 15,501,800 Common Shares, representing approximately 9.7% of the issued and outstanding Common Shares on a non-diluted basis as at April 14, 2021. Following the completion of the Transaction, together with all previous acquisitions of Common Shares by Sundial, the Company now owns 16,040,200 Common Shares, representing approximately 10.1% of the issued and outstanding Common Shares on a non-diluted basis as at April 14, 2021. Sundial's average cost base for the Common Shares, including those acquired in the Transaction, is $2.670 per Common Share.

The Company acquired the securities reported herein for investment purposes. The Company may, depending on market and other conditions, increase or decrease its beneficial ownership in Valens' securities, whether in transactions over the open market, by privately negotiated arrangements or otherwise, subject to a number of factors, including general market conditions and other available investment and business opportunities.

This news release is being issued to comply with National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues. An early warning report regarding these transactions has been filed on the System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com under Valens' issuer profile and may be obtained directly from Sundial upon request at the telephone number below. Sundial's head office is located at #300, 919 - 11th Avenue SW, Calgary, AB T2R 1P3. Valens' head office address is 96 Spadina Avenue, Suite 400, Toronto, Ontario M5V 2J6.

About Sundial Growers Inc. 

Sundial is a public company with Common Shares traded on Nasdaq under the symbol "SNDL".

Sundial is a licensed producer that crafts cannabis using state-of-the-art indoor facilities. Our 'craft-at-scale' modular growing approach, award-winning genetics and experienced growers set us apart. 

Our Canadian operations cultivate small-batch cannabis using an individualized "room" approach, with 448,000 square feet of total available space.  

Sundial's brand portfolio includes Top Leaf, Sundial Cannabis, Palmetto and Grasslands. Our consumer-packaged goods experience enables us to not just grow quality cannabis, but also to create exceptional consumer and customer experiences.  

We are proudly Albertan, headquartered in Calgary, AB, with operations in Olds, AB, and Rocky View County, AB.  

Forward-Looking Information Cautionary Statement  
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"), including, but not limited to, statements regarding the Company's potential further investment in or divestment of Common Shares of Valens. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "likely", "outlook", "forecast", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Please see "Item 3D Risk Factors" in the Company's Annual Report on Form 20-F, which was filed with the Securities and Exchange Commission ("SEC") on March 17, 2021, and the risk factors included in our other SEC filings for a discussion of the material risk factors that could cause actual results to differ materially from the forward-looking information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. 

View original content to download multimedia:http://www.prnewswire.com/news-releases/sundial-files-early-warning-report-issued-pursuant-to-national-instrument-62-103-301282849.html

SOURCE Sundial Growers Inc.

FAQ

What percentage of Valens does Sundial own as of May 2021?

As of May 2021, Sundial owns approximately 10.1% of The Valens Company.

How much did Sundial pay for its acquisition of Valens shares?

Sundial paid a total of $1.972 million for the acquisition of 538,400 shares.

What is the average cost per share Sundial paid for Valens shares?

Sundial's average cost per share for Valens is $2.670.

What transaction occurred between Sundial and Valens on May 3, 2021?

On May 3, 2021, Sundial acquired 538,400 common shares of Valens.

What is the significance of Sundial's investment in Valens?

The investment increases Sundial's stake and strategic influence in the cannabis sector.